SCHEMBL28809999

SCHEMBL28809999

Clc1cc2cnccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.53
PDE3B Q13370 1/20 0.50
PDE3A Q14432 1/20 0.50
MAPT P10636 1/20 0.43
SNCA P37840 1/20 0.43
HRH4 Q9H3N8 1/20 0.41
CHUK O15111 3/20 0.41
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
DYRK1A Q13627 4/20 0.38
CLK2 P49760 3/20 0.38
CLK3 P49761 3/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27969894 0.83 DAO (0.53) DAOPDE3BPDE3AMAPTSNCA
SCHEMBL4805509 0.75 DAO (0.53) DAOPDE3BPDE3AMAPTSNCA
SCHEMBL1853725 0.75 DAO (0.53) DAOPDE3BPDE3AMAPTSNCA
SCHEMBL28383003 0.75 DAO (0.53) DAOPDE3BPDE3AMAPTSNCA
SCHEMBL31691908 0.75 DAO (0.53) DAOPDE3BPDE3AMAPTSNCA
SCHEMBL27851181 0.75 DAO (0.53) DAOPDE3BPDE3AMAPTSNCA
SCHEMBL20004291 0.75 DAO (0.53) DAOPDE3BPDE3AMAPTSNCA
SCHEMBL19362482 0.75 DAO (0.49) DAOPDE3BPDE3AMAPTSNCA
SCHEMBL5314190 0.72 MAPT (0.51) DAOPDE3BPDE3AMAPTSNCA
SCHEMBL24492928 0.71 DAO (0.49) DAOPDE3BPDE3AMAPTSNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111196804-B TGF-beta R1 inhibitors and uses thereof 南京圣和药业股份有限公司 2023-11-07 CN disclosed
CN-105683175-B Two ring inhibitor 卡尔维斯塔制药有限公司 2018-04-03 CN disclosed
CN-104955824-B It is used as the aminopyrimidine compounds of the inhibitor of the EGFR mutant containing T790M 豪夫迈·罗氏有限公司 2017-09-22 CN disclosed
CN-105683175-A BICYCLIC INHIBITORS 卡尔维斯塔制药有限公司 2016-06-15 CN disclosed
CN-104955824-A Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants GENENTECH INC 2015-09-30 CN disclosed
CN-102046240-B Novel P2X7R antagonists and their use AFFECTIS PHARMACEUTICALS AG 2014-06-25 CN disclosed
CN-103492376-A Bicyclic heterocycle compounds and their uses in therapy ASTEX THERAPEUTICS LTD 2014-01-01 CN disclosed